Mark Sabag, EVP, International Markets at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 100,000 shares at $13.52 ($1.4M) on 2024-03-05, disclosed to the SEC on 2024-03-07.
Seasonal sale ($1.4M) by EVP, International Markets — this insider has traded TEVA in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| TEVA | SELL | 2025-12-11 | $9.0M | — | Filing → |
| TEVA | SELL | 2025-05-12 | $12.2M | — | Filing → |
| TEVA | SELL | 2025-02-14 | $5.8M | — | Filing → |